LncRNA bladder cancer associated transcript 1 (BLACAT1) knockdown was reported to reverse afatinib resistance in NSCLC through modulation of STAT3 signalling [119]. This evidence concerns the gene BLACAT1 and non-small cell lung carcinoma.